The CLOCK trial, a double ‐blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/mL plus EDTA 30 mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis

Discussion The CLOCK Trial suggests TSC and M‐EDTA may preserve catheter patency better than H. TSC may be a better option due the lack of association with long‐term antimicrobial resistance.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fhdi.12492

Source: Hemodialysis International - September 25, 2016 Category: Hematology Authors: Marcus V. S. Jo ão Luiz, Cristoforo Sacavone, Carmen Tzanno Tags: Original Article Source Type: research